KIT and chronic myelogenous leukemia, BCR-ABL1 positive: To assess the expression of G0M in CML LSCs, we subdivided the conventional CML LSC fraction (CML LSK; BCR-ABL1+Lin−Sca1+cKit+) in the BM from leukemic mice by G0M and CD27, a marker for the CML stem/progenitor cell fraction45.